Estudiado en personas
Existen estudios publicados en personas. No es un medicamento autorizado en Estados Unidos ni en la Unión Europea.
Esta página es un esbozo
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
Qué tan sólida es la evidencia
Hasta dónde ha llegado
Todo medicamento sube la misma escalera. La mayoría de los compuestos nunca llega a lo más alto, y el lugar que ocupa indica cuánto pueden sostener sus afirmaciones.
- Medicamento autorizado
Un regulador ha revisado los ensayos y lo ha autorizado para un uso concreto.
- Fase 3
Ensayos aleatorizados grandes, a menudo con miles de personas, frente a placebo o un tratamiento estándar.
- Fase 2
Ensayos de tamaño medio que miden la dosis frente al efecto en personas con la enfermedad.
- Fase 1 y estudios humanos iniciales: LL-37
Primeros estudios en personas: seguridad y cómo el organismo lo procesa.
- Células y animales
Trabajo de laboratorio y con animales. Un resultado en animales no es un resultado en personas.
- 2,555
- artículos en PubMed
- 1,844
- de ellos en personas
- 38
- ensayos aleatorizados
- 266
- revisiones
Un recuento indica cuánto se ha publicado, no lo que encontró. Contado en PubMed: 2026-11-16
Manipulación y reconstitución
Del polvo a una muestra medida
Los mismos cuatro pasos para cualquier vial liofilizado. Manipulación de laboratorio, no uso en una persona.
1. Lea el vial
La etiqueta indica la masa de péptido en el vial, en miligramos. Ese número es el punto de partida de todo cálculo.
2. Añada el diluyente
Se añade un volumen medido de diluyente lentamente, por la pared del vidrio. Haga girar con suavidad; agitar puede dañar un péptido.
3. Calcule la concentración
La concentración es la masa dividida por el volumen: 10 mg en 2 mL son 5 mg por mL.
4. Mida la muestra
El volumen es la masa deseada dividida por la concentración. En una jeringa U-100, 1 mL equivale a 100 unidades.
La calculadora de abajo hace la aritmética y muestra el procedimiento.
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on LL-37 itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of LL-37; no amount here is a recommendation.
LL-37: en PubMed
What PubMed held for LL-37 on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 2,555
- papers
- 1,844
- in humans
- 60
- clinical trials
- 38
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis
TrialNakatsuji T, Chen TH, Narala S, et al. Science translational medicine, 2017. PMID 28228596
- The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12(®) in infant colic: A randomised, double blind, placebo-controlled trial
Randomized trialNocerino R, De Filippis F, Cecere G, et al. Alimentary pharmacology & therapeutics, 2020. PMID 31797399
- Acute salivary antimicrobial peptide secretion response to different exercise intensities and durations
Randomized trialIto R, Uchino T, Uchida M, et al. American journal of physiology. Regulatory, integrative and comparative physiology, 2024. PMID 39155711
- Niacinamide leave-on formulation provides long-lasting protection against bacteria in vivo
TrialMathapathi MS, Mallemalla P, Vora S, et al. Experimental dermatology, 2017. PMID 28094872
- Cationic antimicrobial peptides and periodontal physiopathology: A systematic review
ReviewJourdain ML, Velard F, Pierrard L, et al. Journal of periodontal research, 2019. PMID 31215656
- Diagnostic value of anti-microbial peptide, cathelicidin in congenital pneumonia
TrialGad GI, Abushady NM, Fathi MS, et al. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2015. PMID 25354286
- LL-37: A Direct Link Between Inflammation and Myocardial Infarction
StudySchneider DJ JACC. Basic to translational science, 2024. PMID 39170953
- Role of LL-37 in thrombotic complications in patients with COVID-19
StudyDuan Z, Zhang J, Chen X, et al. Cellular and molecular life sciences : CMLS, 2022. PMID 35596804
Search used: ("LL-37"[tiab]). Run it on PubMed
Enlaces de investigación
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for LL-37 on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.